Full Answer
How can I get help with access to Novartis medicines?
The Novartis Patient Assistance Foundation, Inc. (NPAF) may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage . You may be eligible to receive your Novartis medicine (s) for free. If you are seeking NPAF assistance for the first time, you must submit the PANO SRF.
What is the Novartis Patient Assistance Foundation?
The Novartis Patient Assistance Foundation, Inc. (NPAF) may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage. You may be eligible to receive your Novartis medicine (s) for free.
Does Novartis Promacta have a co-pay card?
Universal Co-pay Card You may be eligible for immediate co-pay savings on your next PROMACTA prescription. Eligible patients with private insurance may pay $0 per month Novartis will pay the remaining co-pay, up to $15,000 per calendar year, per product*
Are there any exceptions to the Novartis Patient Assistance Foundation’s prescription coverage?
‡Exceptions exist for individuals with limited prescription coverage. Please be advised that access to the medicines distributed through the Novartis Patient Assistance Foundation, Inc., is free of charge to all eligible patients.
What is Novartis patient support?
What is the med number for Promacta?
How to contact Novartis oncology?
How to find out if you are eligible for Novartis?
How to contact NPAF?
What should be measured prior to initiation of Promacta?
Does Promacta cause hepatotoxicity?
See 2 more
About this website
Does Novartis have a patient assistance program?
Novartis Patient Assistance Foundation provides medicines at no cost to eligible US patients who are experiencing financial hardship.
Does Janssen have a patient assistance program?
Janssen is committed to helping patients obtain appropriate access to our medicines. We partner with private and public payers and healthcare systems to support availability of our products and we offer and support a variety of programs and services to assist with access to and appropriate use of new treatment options.
Where can I find promacta?
Novartis provides eligible patients with a temporary supply of PROMACTA. Contact us at 1-800-282-7630 to get more information. To enroll now: Call 1-800-282-7630 or visit Patient.NovartisOncology.com.
Does Pfizer have a patient assistance program?
Pfizer RxPathways® patients in need get access to their Pfizer medicines. Today, Pfizer RxPathways® connects eligible U.S. patients to a range of Pfizer assistance programs that provide insurance support, co-pay help, and medicines for free or at a savings.
What can I use my Janssen CarePath card for?
The Janssen CarePath Savings Program is designed to help lower eligible patients' out-of-pocket medication costs for their Janssen medication. Eligible patients using commercial or private insurance to pay for their Janssen medication will receive savings off their deductible, co-pay, and co-insurance medication costs.
What is Jansen care path?
Janssen CarePath is your one source for resources focused on access, affordability, and treatment support for your patients. Our Care Coordinator team supports all the Janssen products you prescribe. We can help make it easier for you and your patients to get the resources you both may need.
Does Medicare pay for PROMACTA?
Do Medicare prescription drug plans cover Promacta? Yes. 100% of Medicare prescription drug plans cover this drug.
Is there a generic for PROMACTA?
Eltrombopag is the generic name for the trade name drug Promacta. In some cases, health care professionals may use the trade name, Promacta, when referring to the generic drug name, eltrombopag.
Is PROMACTA a chemo drug?
Eltrombopag (Promacta) is an FDA approved drug for the treatment of chronic idiopathic thrombocytopenic purpura (ITP)- a condition of having an abnormally low platelet count....Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia.Masking:None (Open Label)Primary Purpose:Prevention9 more rows
How do you qualify for free eliquis?
You may be eligible for the Free 30-Day Trial Offer for ELIQUIS® (apixaban) if:You have not previously filled a prescription for ELIQUIS;You have a valid 30-day prescription for ELIQUIS;You are being treated with ELIQUIS for an FDA-approved indication that an HCP has planned for more than 35 days of treatment;More items...
What is Pfizer enCompass?
Pfizer enCompass offers various services to patients including reimbursement support for insured patients; co-pay assistance for eligible commercially insured patients who cannot afford their co-pays, co-insurances, or deductibles; and a free medicine patient assistance program for eligible uninsured or underinsured ...
What is Pfizer connect?
The Pfizer Patient Assistance Program provides certain medicines for free to eligible financially needy insured and uninsured patients.
How do you qualify for free eliquis?
You may be eligible for the Free 30-Day Trial Offer for ELIQUIS® (apixaban) if:You have not previously filled a prescription for ELIQUIS;You have a valid 30-day prescription for ELIQUIS;You are being treated with ELIQUIS for an FDA-approved indication that an HCP has planned for more than 35 days of treatment;More items...
What medications does Johnson and Johnson make?
Web Site AddressALZHEIMER'S DISEASE RAZADYNE® www.janssen.com/us. ANTI-COAGULANTS.XARELTO® www.xarelto.com. ANTI-FUNGALS.or Oral Solution. www.janssen.com/us. ... SIRTURO® www.sirturo.com. ... HALDOL® www.janssen.com/us. ... INVEGA SUSTENNA® www.invegasustenna.com. ... RISPERDAL® www.janssen.com/us. ... SPRAVATO™ www.janssen.com/us.More items...
Does Janssen make Remicade?
Janssen CarePath Savings Program can help eligible patients save on their out-of-pocket medication costs for REMICADE®. Your eligible patients will pay $5 per infusion with a $20,000 maximum program benefit per calendar year.
What drug company makes Xarelto?
To date, XARELTO® is approved in more than 110 countries worldwide and has been successfully launched in more than 80 countries by Bayer HealthCare. Janssen Pharmaceuticals, Inc.
How to contact Novartis oncology?
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-844-PRO-MACT (1-844-776-6228). To find out if you are eligible for the Novartis Oncology Universal Co-pay Program today:
What is PANO on Novartis?
Our Patient Assistance Now Oncology (PANO) support center offers a single point of contact from Novartis to help guide you through getting access to the medicine prescribed by your doctor— from insurance verification to information about financial assistance.
Does Novartis have a third party insurance?
The Novartis Patient Assistance Foundation, Inc. (NPAF) may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage . You may be eligible to receive your Novartis medicine (s) for free.
Do you have to submit NPAF for the first time?
If you are seeking NPAF assistance for the first time, you must submit the PANO SRF.
Does Promacta increase liver damage?
PROMACTA may increase your risk of liver problems that may be... See More
Patient Assistance Now Oncology
Our Patient Assistance Now Oncology (PANO) support center offers a single point of contact from Novartis to help guide you through getting access to the medicine prescribed by your doctor— from insurance verification to information about financial assistance.
Free trial program
If you have been prescribed PROMACTA ® (eltrombopag), you may be eligible to receive a free 14-day supply to help you begin therapy via mail. You will need to complete a Patient Assistance Now Oncology Service Request Form (PANO SRF) to see if you qualify (for FDA‑approved uses/indications only).
Universal Co-pay Card
You may be eligible for immediate co-pay savings on your next PROMACTA prescription.
Novartis Patient Assistance Foundation (NPAF)
The Novartis Patient Assistance Foundation, Inc., may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage. You may be eligible to receive your Novartis medicine (s) for free.
How to contact Novartis oncology?
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-844-PRO-MACT (1-844-776-6228). To find out if you are eligible for the Novartis Oncology Universal Co-pay Program today:
What is Promacta used for?
PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to persistent or chronic immune thrombocytopenia ( ITP) when other medicines to treat your ITP or surgery to remove the spleen have not worked well enough. ...
What is PANO on Novartis?
Our Patient Assistance Now Oncology (PANO) support center offers a single point of contact from Novartis to help guide you through getting access to the medicine prescribed by your doctor— from insurance verification to information about financial assistance.
Does Novartis have a third party insurance?
The Novartis Patient Assistance Foundation, Inc. (NPAF) may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage . You may be eligible to receive your Novartis medicine (s) for free.
What is Novartis patient support?
Novartis Oncology Patient Support is designed to help meet the needs of patients and caregivers by making it easier to access Novartis Oncology medicine (s). Our patient support programs include financial assistance, information about lifestyle support, and more.
What is the med number for Promacta?
To learn more, call 1-800-282-7630 or visit HCP.Novartis.com/Access. Indications for PROMACTA® (eltrombopag) PROMACTA is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia. PROMACTA is indicated for the treatment ...
How to contact Novartis oncology?
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-877-577-7756. Encourage your patients to find out if they are eligible to enroll in the Novartis Oncology Universal Co-pay Program by visiting Copay.NovartisOncology.com or calling 1-877-577-7756.
How to find out if you are eligible for Novartis?
Your patients can learn if they are eligible for the Novartis Oncology Universal Co-pay Program by visiting Copay.NovartisOncology.com or calling 1-877-577-7756
How to contact NPAF?
To learn more, call NPAF at 1-800-277-2254 or visit PAP.Novartis.com
What should be measured prior to initiation of Promacta?
First-line treatment of severe aplastic anemia. ALT, AST, and bilirubin should be measured prior to initiation of PROMACTA. During treatment, increases in ALT levels should be managed based on recommendation in Dosing and Administration section for hepatic impairment.
Does Promacta cause hepatotoxicity?
PROMACTA may increase the risk of severe and potentially life-threatening hepatotoxicity. Monitor hepatic function and discontinue dosing as recommended. PROMACTA may increase the risk of severe and potentially life-threatening hepatotoxicity.
When to use Promacta?
PROMACTA should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase the risk for bleeding. PROMACTA is indicated for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. PROMACTA should be used only in patients ...
What are the adverse reactions to Promacta?
The most common adverse reactions (≥5%) in a single-arm trial of 92 patients 2 years and older with severe aplastic anemia (SAA) who had not received prior immunosuppressive therapy were increased ALT (29%) and AST (17%), blood bilirubin increased (17%), rash (8%), and skin discoloration including hyperpigmentation (5%). Upper respiratory infection, particularly in pediatric patients, was also reported. The most common adverse reactions (≥20%) in a single-arm, open-label trial in 43 patients with refractory SAA who received PROMACTA were nausea (33%), fatigue (28%), cough (23%), diarrhea (21%), and headache (21%). In this trial, patients had bone marrow aspirates evaluated for cytogenetic abnormalities. Eight patients had a new cytogenetic abnormality reported, including 5 patients who had complex changes in chromosome 7. If new cytogenetic abnormalities are observed, consider discontinuation of PROMACTA.
How long after discontinuation of Promacta can you get CBCs?
Obtain CBCs with differentials, including platelet counts, weekly for at least 4 weeks following discontinuation of PROMACTA
What is Promacta used for?
PROMACTA is indicated for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
How often does promacta worsen cataracts?
Development or worsening of cataracts with PROMACTA has been reported with a frequency of 5% to 11% in 6 clinical studies
What should be measured prior to initiation of Promacta?
First-line treatment of severe aplastic anemia. ALT, AST, and bilirubin should be measured prior to initiation of PROMACTA. During treatment, increases in ALT levels should be managed based on recommendation in Dosing and Administration section for hepatic impairment.
How long does it take for promacta to work?
Hematologic response may take up to 16 weeks after starting PROMACTA. If no hematologic response has occurred after 16 weeks with PROMACTA, discontinue therapy
How to contact Novartis oncology?
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-844-PRO-MACT (1-844-776-6228). To find out if you are eligible for the Novartis Oncology Universal Co-pay Program today:
What is Promacta used for?
Approved Uses for PROMACTA® (eltrombopag) PROMACTA is a prescription medicine used to treat adults and children 1 year and older with low blood platelet counts due to persistent or chronic immune thrombocytopenia (ITP) when other medicines to treat your ITP or surgery to remove the spleen have not worked well enough.
Does Novartis have a third party insurance?
The Novartis Patient Assistance Foundation, Inc., may help provide access to Novartis medicines if you are experiencing financial hardship and/or have no third-party insurance coverage. You may be eligible to receive your Novartis medicine (s) for free. To be eligible for NPAF assistance, you must: Be a US resident.
What is Novartis patient support?
Novartis Oncology Patient Support is designed to help meet the needs of patients and caregivers by making it easier to access Novartis Oncology medicine (s). Our patient support programs include financial assistance, information about lifestyle support, and more.
What is the med number for Promacta?
To learn more, call 1-800-282-7630 or visit HCP.Novartis.com/Access. Indications for PROMACTA® (eltrombopag) PROMACTA is indicated in combination with standard immunosuppressive therapy for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia. PROMACTA is indicated for the treatment ...
How to contact Novartis oncology?
For full Terms and Conditions, visit Copay.NovartisOncology.com or call 1-877-577-7756. Encourage your patients to find out if they are eligible to enroll in the Novartis Oncology Universal Co-pay Program by visiting Copay.NovartisOncology.com or calling 1-877-577-7756.
How to find out if you are eligible for Novartis?
Your patients can learn if they are eligible for the Novartis Oncology Universal Co-pay Program by visiting Copay.NovartisOncology.com or calling 1-877-577-7756
How to contact NPAF?
To learn more, call NPAF at 1-800-277-2254 or visit PAP.Novartis.com
What should be measured prior to initiation of Promacta?
First-line treatment of severe aplastic anemia. ALT, AST, and bilirubin should be measured prior to initiation of PROMACTA. During treatment, increases in ALT levels should be managed based on recommendation in Dosing and Administration section for hepatic impairment.
Does Promacta cause hepatotoxicity?
PROMACTA may increase the risk of severe and potentially life-threatening hepatotoxicity. Monitor hepatic function and discontinue dosing as recommended. PROMACTA may increase the risk of severe and potentially life-threatening hepatotoxicity.
